These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

543 related articles for article (PubMed ID: 28917515)

  • 1. Cerebral Embolic Protection During Transcatheter Aortic Valve Replacement Significantly Reduces Death and Stroke Compared With Unprotected Procedures.
    Seeger J; Gonska B; Otto M; Rottbauer W; Wöhrle J
    JACC Cardiovasc Interv; 2017 Nov; 10(22):2297-2303. PubMed ID: 28917515
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rate of peri-procedural stroke observed with cerebral embolic protection during transcatheter aortic valve replacement: a patient-level propensity-matched analysis.
    Seeger J; Kapadia SR; Kodali S; Linke A; Wöhrle J; Haussig S; Makkar R; Mehran R; Rottbauer W; Leon M
    Eur Heart J; 2019 May; 40(17):1334-1340. PubMed ID: 30590554
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical Outcomes of Sentinel Cerebral Protection System Use During Transcatheter Aortic Valve Replacement: A Systematic Review and Meta-Analysis.
    Ndunda PM; Vindhyal MR; Muutu TM; Fanari Z
    Cardiovasc Revasc Med; 2020 Jun; 21(6):717-722. PubMed ID: 31175048
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Significant Differences in Debris Captured by the Sentinel Dual-Filter Cerebral Embolic Protection During Transcatheter Aortic Valve Replacement Among Different Valve Types.
    Seeger J; Virmani R; Romero M; Gonska B; Rottbauer W; Wöhrle J
    JACC Cardiovasc Interv; 2018 Sep; 11(17):1683-1693. PubMed ID: 30154060
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Complete filter-based cerebral embolic protection with transcatheter aortic valve replacement.
    Van Gils L; Kroon H; Daemen J; Ren C; Maugenest AM; Schipper M; De Jaegere PP; Van Mieghem NM
    Catheter Cardiovasc Interv; 2018 Mar; 91(4):790-797. PubMed ID: 28895285
    [TBL] [Abstract][Full Text] [Related]  

  • 6. First-in-Man Study Evaluating the Emblok Embolic Protection System During Transcatheter Aortic Valve Replacement.
    Latib A; Mangieri A; Vezzulli P; Spagnolo P; Sardanelli F; Fellegara G; Pagnesi M; Giannini F; Falini A; Gorla R; Montorfano M; Bedogni F; Colombo A; Popma J; Merhi WM; De Marco F
    JACC Cardiovasc Interv; 2020 Apr; 13(7):860-868. PubMed ID: 32273098
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neurological Outcomes With Embolic Protection Devices in Patients Undergoing Transcatheter Aortic Valve Replacement: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
    Giustino G; Mehran R; Veltkamp R; Faggioni M; Baber U; Dangas GD
    JACC Cardiovasc Interv; 2016 Oct; 9(20):2124-2133. PubMed ID: 27765306
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cerebral embolic protection device utilization and outcomes in transcatheter aortic valve replacement: A nationally representative propensity matched analysis.
    Altibi AM; Alhuneafat L; Jabri A; Al-Abdouh A; Ghanem F
    Cardiovasc Revasc Med; 2024 Oct; 67():112-114. PubMed ID: 38653674
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early Clinical Impact of Cerebral Embolic Protection in Patients Undergoing Transcatheter Aortic Valve Replacement.
    Kroon HG; van der Werf HW; Hoeks SE; van Gils L; van den Berge FR; El Faquir N; Rahhab Z; Daemen J; Poelman J; Schurer RAJ; van den Heuvel A; de Jaegere P; van der Harst P; Van Mieghem NM
    Circ Cardiovasc Interv; 2019 Jun; 12(6):e007605. PubMed ID: 31195822
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TriGuard
    Samim M; van der Worp B; Agostoni P; Hendrikse J; Budde RP; Nijhoff F; Ramjankhan F; Doevendans PA; Stella PR
    Catheter Cardiovasc Interv; 2017 Feb; 89(3):470-477. PubMed ID: 27121306
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of Cerebral Embolic Protection Devices on Disabling Stroke After TAVR: Updated Results From the STS/ACC TVT Registry.
    Butala NM; Kapadia SR; Secemsky EA; Gallup D; Kosinski AS; Vemulapalli S; Messenger JC; Yeh RW; Cohen DJ
    Circ Cardiovasc Interv; 2024 Sep; 17(9):e013697. PubMed ID: 38837174
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cerebral embolic protection during transcatheter aortic valve replacement: a systematic review and meta-analysis of propensity score matched and randomized controlled trials using the Sentinel cerebral embolic protection device.
    Wolfrum M; Handerer IJ; Moccetti F; Schmeisser A; Braun-Dullaeus RC; Toggweiler S
    BMC Cardiovasc Disord; 2023 Jun; 23(1):306. PubMed ID: 37330463
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Debris Heterogeneity Across Different Valve Types Captured by a Cerebral Protection System During Transcatheter Aortic Valve Replacement.
    Schmidt T; Leon MB; Mehran R; Kuck KH; Alu MC; Braumann RE; Kodali S; Kapadia SR; Linke A; Makkar R; Naber C; Romero ME; Virmani R; Frerker C
    JACC Cardiovasc Interv; 2018 Jul; 11(13):1262-1273. PubMed ID: 29976363
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Embolic protection in patients undergoing transaortic transcatheter aortic valve replacement: initial experience with the TriGuard HDH embolic deflection device.
    Campelo-Parada F; Regueiro A; Dumont E; DeLarochellière R; Paradis JM; Mohammadi S; Doyle D; Rodés-Cabau J
    J Card Surg; 2016 Oct; 31(10):617-622. PubMed ID: 27577965
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neurological Events Following Transcatheter Aortic Valve Replacement and Their Predictors: A Report From the CoreValve Trials.
    Kleiman NS; Maini BJ; Reardon MJ; Conte J; Katz S; Rajagopal V; Kauten J; Hartman A; McKay R; Hagberg R; Huang J; Popma J;
    Circ Cardiovasc Interv; 2016 Sep; 9(9):. PubMed ID: 27601429
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 1-Year Clinical Outcomes in Women After Transcatheter Aortic Valve Replacement: Results From the First WIN-TAVI Registry.
    Chieffo A; Petronio AS; Mehilli J; Chandrasekhar J; Sartori S; Lefèvre T; Presbitero P; Capranzano P; Tchetche D; Iadanza A; Sardella G; Van Mieghem NM; Meliga E; Dumonteil N; Fraccaro C; Trabattoni D; Mikhail G; Sharma S; Ferrer MC; Naber C; Kievit P; Baber U; Snyder C; Sharma M; Morice MC; Mehran R;
    JACC Cardiovasc Interv; 2018 Jan; 11(1):1-12. PubMed ID: 29301640
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety and performance of a novel embolic deflection device in patients undergoing transcatheter aortic valve replacement: results from the DEFLECT I study.
    Baumbach A; Mullen M; Brickman AM; Aggarwal SK; Pietras CG; Forrest JK; Hildick-Smith D; Meller SM; Gambone L; den Heijer P; Margolis P; Voros S; Lansky AJ
    EuroIntervention; 2015 May; 11(1):75-84. PubMed ID: 25868876
    [TBL] [Abstract][Full Text] [Related]  

  • 18. First-in-man use of a novel embolic protection device for patients undergoing transcatheter aortic valve implantation.
    Naber CK; Ghanem A; Abizaid AA; Wolf A; Sinning JM; Werner N; Nickenig G; Schmitz T; Grube E
    EuroIntervention; 2012 May; 8(1):43-50. PubMed ID: 22403768
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cerebral protection devices during transcatheter aortic valve implantation.
    Vlastra W; Vendrik J; Koch KT; Baan J; Piek JJ; Delewi R
    Trends Cardiovasc Med; 2018 Aug; 28(6):412-418. PubMed ID: 29428159
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cerebral embolic protection systems for transcatheter aortic valve replacement.
    Gasior T; Mangner N; Bijoch J; Wojakowski W
    J Interv Cardiol; 2018 Dec; 31(6):891-898. PubMed ID: 30467892
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.